Advertisement

Topics

Amorfix Life Sciences Ltd. (AMF) - Medical Equipment - Deals and Alliances Profile

03:42 EDT 8 Jun 2015 | BioPortfolio Reports

Recently added to the BioPortfolio report store, Amorfix Life Sciences Ltd. (AMF) - Medical Equipment - Deals and Alliances Profile is a new report from GlobalData published on 2015-04-23. This 57-page report is available in PDF from $250.

Summary

Amorfix Life Sciences Ltd. (Amorfix) is a development stage biopharmaceutical company. It focuses on the development of therapeutic antibodies and diagnostics for the treatment of misfolded protein diseases. The company uses ProMIS technology, which helps in predicting new disease specific epitopes on the molecular surface of misfolded proteins. Based on ProMIS technology, the company is developing antibody therapeutics and diagnostics targeting cancer and amyotrophic lateral sclerosis (ALS). The company developed two new technologies, namely, Epitope Protection and AMFIA for identifying low levels of misfolded proteins in the biological samples which helped in generating cerebrospinal fluid screening test for Alzheimer’s disease. The company's products and services include therapeutics, diagnostic kits, diagnostic services, and reagents. Amorfix is headquartered in Mississauga, Ontario, Canada.

As a part of its overall strategy to build its product pipeline, the company establishes partnerships and strategic alliances to accelerate the discovery, development and commercialization of its therapeutic antibodies. To this end the company recently entered into a collaboration agreement with Trellis Bioscience for developing antibodies against misfolded CD38 protein for the treatment of haematological malignancies such as leukemia and lymphoma.

Amorfix Life Sciences Ltd. (AMF) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of…

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Amorfix Life Sciences Ltd., Medical Equipment, Deals By Year, 2009 to YTD 2015 6
Amorfix Life Sciences Ltd., Medical Equipment Deals By Type, 2009 to YTD 2015 7
Amorfix Life Sciences Ltd., Medical Equipment, Deals By Region, 2009 to YTD 2015 8
Amorfix Life Sciences Ltd., Medical Equipment, Deals By Market, 2009 to YTD 2015 9
Amorfix Life Sciences Ltd., Medical Equipment, Deals Summary, 2009 to YTD 2015 10
Amorfix Life Sciences Ltd., Medical Equipment, Deal Details 11
Partnerships 11
Amorfix Life Sciences Enters Into Licensing Agreement With JSW-Lifesciences 11
Amorfix Life Sciences Enters Into Co-Development Agreement With Trellis Bioscience 13
Amorfix Life Sciences Enters Into Agreement With Pharma Company For Alzheimer's Disease Diagnostic 14
Amorfix Life Sciences Enters Into Co-Development Agreement With QPS Holdings 15
Amorfix Life Sciences Enters Into An Agreement With BioMosaics 16
Equity Offering 17
Amorfix Life Sciences Completes Third Tranche Of Private Placement Of Shares And Warrants For US$1 Million 17
Amorfix Life Sciences Completes Private Placement Of Securities For US$0.4 Million 19
Amorfix Life Sciences Completes Private Placement Of Units For US$0.5 Million 20
Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Shares For US$0.2 Million 21
Amorfix Life Sciences Completes First Tranche Of Private Placement Of Units For US$0.5 Million 22
Amorfix Life Sciences Completes Second And Final Tranche Of Private Placement Of Units For US$0.3 Million 23
Amorfix Life Sciences Completes Private Placement Of Units For US$0.2 Million 24
Amorfix Life Sciences Completes Private Placement Of Units For US$1 Million 25
Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Units For US$0.08 Million 26
Amorfix Life Sciences Terminates Private Placement Of Units For US$2.57 Million 28
Amorfix Life Sciences Completes Private Placement Of US$0.51 Million 30
Amorfix Life Sciences Completes Private Placement Of US$2.71 Million 32
Amorfix Life Sciences Ltd. - Key Competitors 34
Key Employees 35
Locations And Subsidiaries 36
Head Office 36
Recent Developments 37
Strategy And Business Planning 37
Apr 08, 2015: Amorfix Completes Optimization of Alzheimer's Disease Diagnostic and Seeks Strategic Partner for Development and Commercialization of the Assay 37
Financial Announcements 38
Mar 31, 2015: Amorfix Announces Financial Results For Nine-month Period Ended December 31, 2014 38
Nov 12, 2014: Amorfix announces second quarter results for period ending September 30, 2014 40
Aug 07, 2014: Amorfix announces fiscal 2015 first quarter results 42
Jun 13, 2014: Amorfix announces fiscal 2014 year end results 44
Feb 13, 2014: Amorfix announces fiscal 2014 third quarter results 46
Corporate Communications 48
Sep 04, 2014: Amorfix appoints Dr Elliot Goldstein and Mr Warren Whitehead to Board of Directors 48
Aug 20, 2014: Amorfix announces retirement of Dr…

For more information open Amorfix Life Sciences Ltd. (AMF) - Medical Equipment - Deals and Alliances Profile.

SKU: GDME14743D

Original Article: Amorfix Life Sciences Ltd. (AMF) - Medical Equipment - Deals and Alliances Profile

NEXT ARTICLE

More From BioPortfolio on "Amorfix Life Sciences Ltd. (AMF) - Medical Equipment - Deals and Alliances Profile"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.